Cash · 2011–2025
Puma Biotechnology cash
$29.6M−57.2% · FY2025
Puma Biotechnology (PBYI) reported $29.6M in cash for fiscal 2025, −57.2% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $29.6M | −57.2% | Open → |
| FY20242024-12-31 | $69.2M | −18.2% | Open → |
| FY20232023-12-31 | $84.6M | +11.0% | Open → |
| FY20222022-12-31 | $76.2M | +20.7% | Open → |
| FY20212021-12-31 | $63.1M | −26.0% | Open → |
| FY20202020-12-31 | $85.3M | +42.1% | Open → |
| FY20192019-12-31 | $60.0M | −44.6% | Open → |
| FY20182018-12-31 | $108M | +32.7% | Open → |
| FY20172017-12-31 | $81.7M | −58.0% | Open → |
| FY20162016-12-31 | $194M | +516.1% | Open → |
| FY20152015-12-31 | $31.6M | −18.1% | Open → |
| FY20142014-12-31 | $38.5M | −10.5% | Open → |
| FY20132013-12-31 | $43.0M | −68.7% | Open → |
| FY20122012-12-31 | $137M | +157.4% | Open → |
| FY20112011-12-31 | $53.4M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth −4.1%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Puma Biotechnology cash |url=https://companiesranked.com/en/company/puma-biotechnology/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Puma Biotechnology cash. CompaniesRanked. https://companiesranked.com/en/company/puma-biotechnology/cash-on-handBibTeX
@misc{companiesranked-en-company-puma-biotechnology-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Puma Biotechnology cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/puma-biotechnology/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001437749-26-026311 · August 6, 2026
{{cite web |title=Puma Biotechnology cash — 10-Q (0001437749-26-026311) |url=https://www.sec.gov/Archives/edgar/data/1401667/000143774926026311/pbyi20260630_10q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.